Best Performing Stocks Year-to-Date

100 stocks · Updated Mar 25, 2026

Year-to-date performance leaders reflect the stocks generating the most price appreciation since January 1st of the current year. Leading performers include companies reporting earnings beats, receiving regulatory approvals, executing strategic pivots, or simply benefiting from sector momentum. YTD leaders are a useful starting point for momentum research, though historical outperformance does not guarantee future returns and many YTD leaders mean-revert by year end.

StockPriceYTDMarket Cap
BVCBitVentures Limited$8.00+592.11%$12.80B
IBRXImmunityBio, Inc.$7.47+325.77%$8.44B
ERASErasca, Inc.$14.74+270.16%$4.86B
AXTIAXT, Inc.$68.64+196.76%$1.71B
SNDKSandisk Corporation$700.40+195.05%$104.75B
AAOIApplied Optoelectronics, Inc.$112.72+175.14%$8.02B
ALMSAlumis Inc. Common Stock$23.24+154.92%$2.74B
KOSKosmos Energy Ltd.$2.71+154.02%$1.26B
VGVenture Global, Inc.$16.80+146.26%$38.82B
FSLYFastly, Inc.$28.55+139.00%$3.29B
LWLGLightwave Logic, Inc.$7.36+130.56%$628.3M
DAWNDay One Biopharmaceuticals, Inc.$21.37+128.54%$2.20B
AMPXAmprius Technologies, Inc.$17.86+126.24%$2.28B
ICHRIchor Holdings, Ltd.$50.76+126.07%$1.44B
ALMAlmonty Industries Inc. Common Shares$14.87+122.59%$4.94B
UCTTUltra Clean Holdings, Inc.$65.18+117.55%$2.38B
LITELumentum Holdings Inc.$798.00+116.50%$50.43B
AZNAstraZeneca PLC$185.87+102.18%$142.32B
RCATRed Cat Holdings, Inc.$16.30+97.48%$1.28B
CRVSCorvus Pharmaceuticals, Inc.$13.13+97.08%$1.34B
RXTRackspace Technology, Inc.$1.43+96.21%$502.0M
TNGXTango Therapeutics, Inc.$19.57+94.02%$1.82B
RYAMRayonier Advanced Materials Inc.$10.92+92.61%$695.5M
IMMXImmix Biopharma, Inc.$8.48+90.25%$533.8M
MRNAModerna, Inc.$51.55+88.78%$20.76B
DNTHDianthus Therapeutics, Inc.$78.95+86.85%$2.84B
TPLTexas Pacific Land Corporation$533.59+85.78%$35.81B
VALValaris Limited$98.04+85.52%$6.31B
CIENCiena Corporation$428.62+83.27%$54.31B
UAMYUnited States Antimony Corporation$9.16+81.08%$1.13B
SOCSable Offshore Corp.$16.64+80.21%$1.42B
OCGNOcugen, Inc.$1.93+79.26%$544.9M
ELVNEnliven Therapeutics, Inc.$31.13+78.64%$1.79B
AEHRAehr Test Systems$39.02+76.25%$1.23B
ACLXArcellx, Inc.$114.63+75.38%$6.70B
CLYMClimb Bio, Inc.$6.70+74.75%$502.2M
WDCWestern Digital Corporation$300.29+74.31%$99.37B
OISOil States International, Inc.$11.99+74.28%$768.9M
ALLOAllogene Therapeutics, Inc.$2.19+73.72%$562.9M
TRXTRX Gold Corporation$1.32+72.66%$525.1M
NKTRNektar Therapeutics$73.11+72.33%$1.41B
LXULSB Industries, Inc.$15.40+72.24%$948.6M
NMRANeumora Therapeutics, Inc. Common Stock$2.46+69.83%$537.2M
STKLSunOpta Inc.$6.48+69.74%$764.5M
ATEXAnterix Inc.$38.52+69.22%$727.8M
EQNREquinor ASA$39.93+68.98%$82.21B
PTENPatterson-UTI Energy, Inc.$10.88+68.41%$3.61B
BEBloom Energy Corporation$145.80+67.80%$35.51B
VIAVViavi Solutions Inc.$35.55+66.89%$6.58B
VRTVertiv Holdings Co$270.20+66.78%$97.90B
Showing 1-50 of 100 stocks

Get Your Daily Market Recap

TickFlow Daily delivers the top gainers, losers, and signals to your inbox every day at market close. Free.

Frequently Asked Questions

Is YTD performance a good predictor of future returns?

Momentum research shows short-term (1-12 month) performance does have some predictive value over the following 1-6 months. However, many YTD leaders experience mean reversion. Past YTD performance is a useful screening input, not a buy signal on its own.

What typically drives the top YTD performers?

Earnings beats, product launches, M&A activity, regulatory approvals (especially in healthcare and cannabis), short squeezes, sector rotations, and macro tailwinds are the most common catalysts for outperformance in any given year.

Should I buy YTD leaders to follow momentum?

Momentum strategies can work but require strict rules around position sizing and exit triggers. Chasing YTD leaders without understanding the fundamental catalyst often means buying after the easy gain is already captured.

How does this list change over time?

This list resets at January 1 each year. Early in the year, even small gains land stocks on the list. By year-end, the list reflects the genuine full-year outperformers. The composition changes significantly as the year progresses.

Related Stock Lists